German Law Introducing Biosimilar Substitution Could Lead To Tendering
Executive Summary
A new law in Germany could lead to tendering in the biosimilars space.
You may also be interested in...
Germany Could Introduce Biosimilar Substitution By Pharmacists In Three Years
A German bill aims to cut spending on biologics, but new revisions mean that measures on biosimilar substitution are likely to be delayed by three years.
Germany To Increase Data Requirements For Pricing Orphan And Other Drugs
A new bill going through the German legislative process could oblige manufacturers of orphan drugs and certain other products to submit real-world data from registries that would impact pricing.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.